The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues.EBI
Institute For Medical Research
5'-O-phosphonomethyl-2',3'-dideoxynucleosides: synthesis and anti-HIV activity.EBI
Institute For Medical Research
Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention.EBI
Institute For Medical Research
Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.EBI
Institute For Medical Research
Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.EBI
Institute For Medical Research
Design and synthesis of a simplified inhibitor for XIAP-BIR3 domain.EBI
Institute For Medical Research
Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).EBI
Institute For Medical Research
Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.EBI
Institute For Medical Research
Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors.EBI
Institute For Medical Research
Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).EBI
Institute For Medical Research
Development of paramagnetic probes for molecular recognition studies in protein kinases.EBI
Institute For Medical Research
Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens.EBI
Institute For Medical Research
A p-[18F]fluoroethoxyphenyl bicyclic nucleoside analogue as a potential positron emission tomography imaging agent for varicella-zoster virus thymidine kinase gene expression.EBI
Institute For Medical Research
Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors.EBI
Institute For Medical Research
Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.EBI
Institute For Medical Research
Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.EBI
Institute For Medical Research